BOT 1.45% 34.0¢ botanix pharmaceuticals ltd

Ann: Botanix Update on BTX 1801 Clinical Development, page-11

  1. 108 Posts.
    lightbulb Created with Sketch. 38
    My belief in what this company is going to achieve is unwavering.

    Every BTX1801 update is run via my partner who, admittedly is not a "scientist", works within a specialised blood cancer unit in a major public hospital in NZ. Her applied, real-life knowledge about the significance of these updates is far superior to mine.
    She won't read the full report until later tonight but I simply messaged her "next stage testing is direct picc line in haemodialysis patients" - her response "!!!"

    Further to @darkhawk100 post above, I recommend those who are unsure what exactly this achieves - research picc lines.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
-0.005(1.45%)
Mkt cap ! $624.4M
Open High Low Value Volume
34.0¢ 35.0¢ 34.0¢ $455.6K 1.315M

Buyers (Bids)

No. Vol. Price($)
14 591597 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 111453 7
View Market Depth
Last trade - 11.43am 13/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.